Indeed, coexpression of S100 (usually variable and patchy) and CD34 represents a valuable clue to tyrosine kinase fusion associated mesenchymal neoplasms originating at different anatomic sites [10]. Here, CD34 is linked to mesenchymal cell neoplasm.